News | News By Subject | News by Disease News By Date | Search News

Investor News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Former Allergan (AGN) CEO Pyott Sees $534M Cash Payday After Stock Sale     4/1/2015
VC Firms Band Together to Launch $150M NYC Biotech Fund, Bringing 2,000 New Jobs to the City     4/1/2015
Amgen (AMGN) in the Crosshairs As Biogen (BIIB), Hospira, Merck & Co. (MRK) All Climb on Biosimilar Bandwagon: Citi     4/1/2015
Adamis (ADMP) Plummets More Than 30% After FDA Rejects Its Allergy Shot Application     3/31/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News     3/30/2015
Synergy Pharmaceuticals May Be for Sale     3/27/2015
Analyst: First Quarter Market Meltdown Just "Clockwork," As Biogen (BIIB), Celgene (CELG) Reign     3/27/2015
Conatus Pharma Shares Soar On Successful Emricasan Phase II Results     3/27/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company     3/27/2015
Early-Stage Biotech Star Flagship Ventures Scores $537M for New Fund     3/26/2015
Why Your Last Investment Blew Up     3/26/2015
Biogen (BIIB) Slides For Alzheimer's Drug Wow Analysts, Set Up Fight for Eli Lilly (LLY)     3/23/2015
Juno Therapeutics (JUNO) Post IPO: Ups and Downs But Mostly Ups     3/18/2015
MS Specialist Picks Biogen Idec (BIIB)’s Tecfidera and Plegridy, Teva (TEVA)’s Laquinimod: Analyst     3/17/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015

Featured Stories
Buy This Stock to Bet on Biogen (BIIB) Drug, Says Raymond James & Associates     3/24/2015
Biotechs To Follow In 2015 Off Fresh Insider Moves     1/7/2015
Batu Biologics Releases 2014 Shareholder Letter     1/2/2015
Race Heats Up for Best Hair in Biopharma Contest As Celgene (CELG), Acorda Therapeutics (ACOR) Square Off     12/2/2014
Investors Expect Record Year for Biotech Venture Capital     11/25/2014
Exclusive: Fewer Deals, Capital In Biotech In Q3 But Sector Remains Popular, Says VC     10/20/2014
Full Blown Ebola Epidemic Unlikely In U.S., Says Specialist     10/20/2014
Current Climate The Best For Biotech IPOs In Decades, Says VC     10/20/2014
Walking Dead: Biotech "Zombie" Companies And Why They Are Failing     10/15/2014
BioSpace's List Of The Top 5 Biggest VC Vampires In Biotech     10/10/2014
Cross-Over Investing All The Rage, Say VCs On Panel     10/9/2014
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO     10/8/2014
Venture Capital Pours Into Biotech For Biggest Quarter Since 2012: Report     10/3/2014
Biotech Boom On Third Coast Proves Everything's Bigger In Texas     10/3/2014
What Happened At BioPharm America 2014?     9/24/2014
Mylan N.V. Announces Pricing Of Secondary Public Offering Of A Portion Of Abbott (ABT)'s Ordinary Shares     4/1/2015
Valeant (VRX) Completes Tender Offer For Salix (SLXP)     4/1/2015
Novavax, Inc. (NVAX) Announces Closing Of Public Offering     4/1/2015
Trillium Therapeutics Inc. Announces Pricing Of Public Offering Of Securities     4/1/2015
Coherus Biosciences Prices Upsized Public Offering Of $120.0 Million Of Common Stock     4/1/2015
Egalet Announces Proposed $60 Million Offering Of Convertible Senior Notes Due 2020     4/1/2015
Redemption Of All Of Salix (SLXP)'s Outstanding 6.00% Senior Notes Due 2021     4/1/2015
Cardio3 BioSciences Announces Intention To Conduct A Registered Public Offering In The United States     4/1/2015
Omnicell Regains Nasdaq Listing Compliance     4/1/2015
Grifols (GRFS) 2014 Annual Report On Form 20-F Filed With The SEC On April 1, 2015     4/1/2015
Inogen (INGN)To File Form 12b-25 With Securities And Exchange Commission     4/1/2015
De Blasio Administration Launches Major Funding Initiative To Create Thousands Of Jobs In City's Life Sciences Sector     4/1/2015
PlasmaTech Biopharmaceuticals Provides Strategic Update For 2015 And Review Of 2014 Acheivements     4/1/2015
Flex Pharma (FLKS) Added To Russell 3000®, Russell 2000, And Russell Microcap Indices     4/1/2015
Dicerna (DRNA) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)     4/1/2015

More News
No News Posted on that date

Career Tips
Relypsa (RLYP) Hits the Big Leagues: New Hires in Almost Every Department     3/19/2015
Four Common Job Applicant Weaknesses     3/19/2015
Three Resume Secrets Professionals Swear By     3/19/2015
Booming PTC Therapeutics (PTCT) Means Job Openings     3/5/2015
Most Frequent Post-Job Interview Mistake     3/5/2015
Five Employer Concerns Every Job Applicant Must Address     3/5/2015
HR Exec Reveals In-Demand Jobs at MyoKardia     2/19/2015
Pfizer (PFE) Buy Means Jobs: Make Sure Your References Are an Asset     2/19/2015
7 Job Search Sins     2/19/2015
5 Critical Reference Trends for 2015: Advice From HR Professionals     2/19/2015
5 Perfect Opportunities to Send a Thank You Note During Your Job Search     2/19/2015
Snag a Job: Here's How CSL Behring Makes Hiring Decisions     2/6/2015
Does Changing Ethnic Names on Resumes Improve Getting Hired?     2/5/2015
The One Empty Word to Avoid in a Job Interview     2/5/2015
10 Sure Things of a Successful Resume     2/5/2015

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->